APPLICATION
ANDA215488
TYPE
ANDA
ORIGINAL APPROVAL
2024-10-03
LATEST ACTION
2024-10-03
ROUTE
INTRAVENOUS, INTRAMUSCULAR, RECTAL, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
METHOHEXITAL SODIUMPrescription
METHOHEXITAL SODIUM 500MG/VIAL · INJECTABLE · INJECTION
Approval history
2024-10-03UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.